Evidence map›Paper›PMID 30279966›Full record

ArticleOncotarget2018

Loss of Gadd45b accelerates BCR-ABL-driven CML.

Xiaojin Sha, Barbara Hoffman, Dan A Liebermann

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Roles for GADD45 in Development and Cancer.Advances in experimental medicine and biology · 2022
    Review
  3. Gadd45 Proteins in Immunity 2.0.Advances in experimental medicine and biology · 2022
    Article
  4. GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.Advances in experimental medicine and biology · 2022
    Article
  5. Gadd45 in Normal Hematopoiesis and Leukemia.Advances in experimental medicine and biology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Xiaojin Sha *Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, USA.
Barbara Hoffman *Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, USA.
Dan A LiebermannFels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA, USA.
Temple University · US

Funding

Gadd45 stress sensors in leukemiaR01CA162403 · NCI · TEMPLE UNIV OF THE COMMONWEALTH · PI LIEBERMANN, DAN A · 2012 to 2016
$1.6M
NCI NIH HHS R01 CA162403
6 · The paper itself

Abstract

Gadd45b is a member of Gadd45 stress sensor protein family that also includes Gadd45a & Gadd45g. To investigate the effect of Gadd45b in bcr-abl oncogene driven chronic myeloid leukemia (CML) development, syngeneic wild type lethally irradiated mice were reconstituted with either wild type or Gadd45b null myeloid progenitors transduced with a retroviral vector expressing BCR-ABL. Loss of Gadd45b was observed to accelerate BCR-ABL driven CML development with shortened median mouse survival time. BCR-ABL Gadd45b deficient CML progenitors exhibited increased proliferation and decreased apoptosis, associated with hyper-activation of c-Jun NH

Indexed as

chronic myelogenous leukemiaGadd45astress response proteintumor suppressor

Identifiers

PMID30279966
PMCPMC6161793
OpenAlexW2891300041

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.